These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30486389)

  • 1. Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures.
    Kutlushina A; Khakimova A; Madzhidov T; Polishchuk P
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
    Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
    PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-Sensitive Encoding of Pharmacophore Features.
    Berenger F; Tsuda K
    J Chem Inf Model; 2023 Apr; 63(8):2360-2369. PubMed ID: 37036083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
    Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
    Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A(1), A (2A), A (2B), and A (3) receptor antagonists.
    Sirci F; Goracci L; Rodríguez D; van Muijlwijk-Koezen J; Gutiérrez-de-Terán H; Mannhold R
    J Comput Aided Mol Des; 2012 Nov; 26(11):1247-66. PubMed ID: 23065321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling.
    Hatmal MM; Taha MO
    Future Med Chem; 2017 Jul; 9(11):1141-1159. PubMed ID: 28722471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based pharmacophore modeling 1. Automated random pharmacophore model generation.
    Szwabowski GL; Cole JA; Baker DL; Parrill AL
    J Mol Graph Model; 2023 Jun; 121():108429. PubMed ID: 36804368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5-HT6 Antagonists from Large Commercial Repositories.
    Dobi K; Flachner B; Pukáncsik M; Máthé E; Bognár M; Szaszkó M; Magyar C; Hajdú I; Lőrincz Z; Simon I; Fülöp F; Cseh S; Dormán G
    Chem Biol Drug Des; 2015 Oct; 86(4):864-80. PubMed ID: 25823681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PharmaCore: The Automatic Generation of 3D Structure-Based Pharmacophore Models from Protein/Ligand Complexes.
    De Vita S; Colarusso E; Chini MG; Bifulco G; Lauro G
    J Chem Inf Model; 2024 May; 64(10):4263-4276. PubMed ID: 38728062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.
    Zou J; Xie HZ; Yang SY; Chen JJ; Ren JX; Wei YQ
    J Mol Graph Model; 2008 Nov; 27(4):430-8. PubMed ID: 18786843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists.
    Bernard D; Coop A; MacKerell AD
    J Am Chem Soc; 2003 Mar; 125(10):3101-7. PubMed ID: 12617677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S; Barron MG
    Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations.
    Wieder M; Garon A; Perricone U; Boresch S; Seidel T; Almerico AM; Langer T
    J Chem Inf Model; 2017 Feb; 57(2):365-385. PubMed ID: 28072524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes.
    Kumar SP; Jha PC
    Comb Chem High Throughput Screen; 2018; 21(1):26-40. PubMed ID: 29295689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
    Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
    J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARS: computing three-dimensional alignments for multiple ligands using pairwise similarities.
    Klabunde T; Giegerich C; Evers A
    J Chem Inf Model; 2012 Aug; 52(8):2022-30. PubMed ID: 22794356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
    Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
    J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.